biopharmaceutical manufacturer News
-
GI Innovation sings MoU for a new biopharmaceutical development with Merck
-Accelerating for development of high expression cell line through combination of GI-SMARTTM platform technology of GI Innovation and CHOZN® Platform of Merck -Expecting synergy of both companies for biopharmaceutical development using CHOZN® Platform, supplying subsidiary materials, education consulting, and etc.,. GI Innovation Co., Ltd. announced that it signed MoU for a ...
-
PDA Announces the Jette Christensen Early Career Professional Grant in Memory of Past PDA Chair
PDA today announced the establishment of the Jette Christensen Early Career Professional Grant in memory of the Immediate-Past Chair of the PDA Board of Directors, who passed away on October 24 after a long battle with cancer. As a PDA member, Board Member, and PDA Chair, Jette’s dedication to PDA’s mission of advancing pharmaceutical/biopharmaceutical manufacturing science and ...
-
UK biomanufacturing team to spearhead development of advanced controls to accelerate drug and vaccine manufacturing
A UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the launch of a project that aims to develop automated manufacturing controls for use in the manufacture of biologics. The project, worth a total of £3.1million, including equipment contributions, has received support from Innovate UK, to platform this advanced ...
-
Waters Corporation and NIBRT partner to bring greater control and predictability to biopharmaceutical processing
Waters Corporation (WAT:NYSE) and Ireland’s National Institute for Bioprocessing Research and Training (NIBRT) announced today a collaboration that will create the world’s first database for glycan analysis by UltraPerformance Liquid Chromatography (UPLC). Expected to be available in 2011, NIBRT will develop, maintain and license the database while Waters and NIBRT will co-market it ...
-
As Companies Work Around the Clock to Address COVID-19, BIO Outlines Key Policy Priorities to Prevent the Next Pandemic
The Senate Committee on Health, Education, Labor and Pensions, chaired by Senator Lamar Alexander, will hold an important hearing today to examine lessons learned from the current global health crisis to help make sure we are better prepared for the next pandemic. Public health expert and patient advocate, Dr. Julie Gerberding, will join the discussion, alongside former top policy leaders. The ...
-
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022. The new ...
-
Halifax Biomedical Inc. announces collaboration with GE Healthcare
Halifax Biomedical Inc (HBI), a leading provider of orthopedic diagnostics using ultra high precision stereo x-ray imaging technology, and GE Healthcare have entered into a collaboration to provide HBI’s stereo x-ray based orthopedic clinical measurements to GE’s existing customers. Under a joint development agreement, HBI and GE have created a Halifax imaging upgrade for existing GE ...
-
Lumen Bioscience Announces Publication in Nature Biotechnology Detailing Spirulina-Based Platform for Ultra-Large-Scale Production of Therapeutic Proteins
Researchers describe rapid, low-cost drug development approach Paper also reports preclinical and early clinical data for LMN-101 A common food source has been converted into a biomanufacturing platform that offers a way to rapidly produce mass quantities of biologic drugs for common diseases that currently lack effective treatments. Researchers at Lumen Bioscience report in Nature ...
-
West Wireless Health Institute and GE healthcare to collaborate on technology and educational initiatives
West Wireless Health Institute (WWHI) today announced a collaboration with GE Healthcare, a global leader in health care technology, on a variety of research, technology and educational initiatives focused on accelerating wireless health solutions. GE Healthcare has demonstrated innovative leadership in the emerging wireless health industry. WWHI is forging technology and educational partnerships ...
-
Halifax Biomedical receives FDA Clearance for GE Healthcare XR656+ Halifax Radiostereometry Upgrade
Halifax Biomedical Inc. (HBI) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its HALIFAX RADIOSTEREOMETRY UPGRADE (K182880). The HALIFAX UPGRADE technology adds to GE Healthcare’s Discovery XR656/XR656 Plus x-ray imaging units to provide ultra-high precision in vivo 3D measurements. The HALIFAX RADIOSTEREOMETRY UPGRADE is the first product to be launched ...
-
Ochsner Health System, GE Healthcare, and The Idea Village launch “Wear Your Health” Challenge to help patients with chronic diseases
Ochsner Health System, GE Healthcare (NYSE: GE), and The Idea Village have launched today the “Wear Your Health” challenge. This challenge seeks to identify wearable technology concepts and mobile application solutions that can transform healthcare outcomes by addressing behavior management in patients with chronic disease. Starting today, individuals interested in participating can ...
-
908 Devices increases focus on biotherapeutics with expansion of scientific advisory board
908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the forthcoming appointment of six new individuals to its Scientific Advisory Board (SAB), including Professor Michael Betenbaugh, Dr. Tim Charlebois, Dr. Elena Chernokalskaya, Dr. John Erickson, Professor Krishnedndu Roy and Dr. Gene Schaefer. The ...
-
GE Healthcare and Partners Launch Mission to Train 100,000 Current and Future Indian Healthcare Professionals
GE Healthcare today launched a mission to accelerate the building of a “Yogya Bharat” or “Skilled India” that will improve access to quality healthcare throughout the country. The company has partnered with leading healthcare and education experts to set up healthcare education & training institutes that will provide accredited skill building programs for 12th Standard ...
-
GE Healthcare Strengthens “Make in India” Capability for Accessible, Affordable Healthcare
Manufactures first ever India designed and developed Computed Tomography system – Revolution ACTs Announces a new venture GenWorks Health Pvt. Ltd to cater to the tier II/III towns GE Healthcare, a unit of General Electric Company (NYSE: GE), reiterated its commitment towards ‘Make in India’ by strengthening its R&D, Manufacturing, Supply Chain, Distribution ...
-
LenioBio GmbH announces the appointment of Dr. Dorothee Ambrosius to LenioBio’s Scientific Advisory Board.
Dusseldorf, December 22, 2021 – LenioBio GmbH, a German life science biotech offering a disruptive protein manufacturing technology, ALiCE®, announces the appointment of Dr. Dorothee Ambrosius to LenioBio’s Scientific Advisory Board. “We are thrilled to have such an expert as Dr. Dorothee Ambrosius joining our SAB” said Dr. Ricarda Finnern, CSO of LenioBio. ...
-
GE launches US$250m healthymagination fund
GE (NYSE: GE) has announced the formation of the “GE Healthymagination Fund”, a new equity fund that will make investments in highly promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sciences technologies aligned with the strategic objectives of GE’s Healthymagination initiative. The fund will also support ...
-
Oral Presentation on Antengene`s Anti-CD24 Monoclonal Antibody ATG-031 Selected for SITC`s Top 100 Abstracts
Antengene is proud to announce that the oral presentation for ATG-031 (anti-CD24 monoclonal antibody) presented at the 37th Society for Immunotherapy of Cancer Annual Meeting (SITC 2022) was selected for the SITC top 100 abstracts. ATG-031 is a first-in-class, humanized anti-CD24 antibody. ATG-031 potently binds to CD24-postive tumor cells. ATG-031 blocks the interaction between CD24 and ...
-
CD Formulation Extends Holiday Greetings for 2023 with an Exclusive Discount
CD Formulation, a leading provider of bioformulation and analytical services, is spreading holiday cheer in 2023 with an exciting offer for its valued customers. The company is extending a generous discount on its range of innovative products and services, allowing customers to make the most of their holiday budget. Being at the forefront of the biotechnology industry, CD Formulation provides ...
-
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of new reagent solutions for herpesvirus research, including a range of Human Herpesviruses Antibodies designed to help researchers better understand the structure of Herpesvirus entry and develop new treatments and prevention strategies. The Herpesviridae are a large family ...
-
Insud Pharma and Fresenius Kabi combine efforts to accelerate the growth of mAbxience
This agreement will bring new business to the biotech company, which is expanding its manufacturing capabilities and maintains its identity, brand, and complete team The transaction validates mAbxience differentiated core competencies in the development, manufacturing and commercialization of biopharmaceutical products With this strategic transaction the Spanish group Insud will also have ...
By mAbxience
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you